DK3058374T3 - Fremgangsmåde til diagnose af primær hyperaldosteronisme - Google Patents

Fremgangsmåde til diagnose af primær hyperaldosteronisme Download PDF

Info

Publication number
DK3058374T3
DK3058374T3 DK14789218.6T DK14789218T DK3058374T3 DK 3058374 T3 DK3058374 T3 DK 3058374T3 DK 14789218 T DK14789218 T DK 14789218T DK 3058374 T3 DK3058374 T3 DK 3058374T3
Authority
DK
Denmark
Prior art keywords
diagnosis
procedure
primary hyperaldosteronism
hyperaldosteronism
primary
Prior art date
Application number
DK14789218.6T
Other languages
English (en)
Inventor
Marko Poglitsch
Cornelia Schwager
Oyen Dunja Van
Martin Leitner
Original Assignee
Attoquant Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP20130189386 external-priority patent/EP2863228A1/en
Application filed by Attoquant Diagnostics Gmbh filed Critical Attoquant Diagnostics Gmbh
Application granted granted Critical
Publication of DK3058374T3 publication Critical patent/DK3058374T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743Steroid hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401Proline; Derivatives thereof, e.g. captopril
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood
    • G01N33/492Determining multiple analytes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/723Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2410/00Assays, e.g. immunoassays or enzyme assays, involving peptides of less than 20 animo acids
    • G01N2410/02Angiotensins; Related peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Ecology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steroid Compounds (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK14789218.6T 2013-10-18 2014-10-17 Fremgangsmåde til diagnose af primær hyperaldosteronisme DK3058374T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20130189386 EP2863228A1 (en) 2013-10-18 2013-10-18 Method for diagnosis of primary hyperaldosteronism
EP14152763 2014-01-28
PCT/EP2014/072339 WO2015055825A1 (en) 2013-10-18 2014-10-17 Method for diagnosis of primary hyperaldosteronism

Publications (1)

Publication Number Publication Date
DK3058374T3 true DK3058374T3 (da) 2019-08-26

Family

ID=51794861

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14789218.6T DK3058374T3 (da) 2013-10-18 2014-10-17 Fremgangsmåde til diagnose af primær hyperaldosteronisme

Country Status (13)

Country Link
US (2) US9829496B2 (da)
EP (1) EP3058374B1 (da)
JP (1) JP6397907B2 (da)
CN (1) CN105683760A (da)
AU (1) AU2014336122B2 (da)
BR (1) BR112016007960B8 (da)
CA (1) CA2926382C (da)
DK (1) DK3058374T3 (da)
EA (1) EA035289B1 (da)
ES (1) ES2745099T3 (da)
HU (1) HUE045337T2 (da)
PL (1) PL3058374T3 (da)
WO (1) WO2015055825A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10559377B2 (en) 2013-01-09 2020-02-11 Biomed Concepts Inc. Graphical user interface for identifying diagnostic and therapeutic options for medical conditions using electronic health records
US9829496B2 (en) * 2013-10-18 2017-11-28 Attoquant Diagnostics Gmbh Method for diagnosis of primary hyperaldosteronism
WO2017127459A1 (en) * 2016-01-19 2017-07-27 Biomed Concepts Inc. Method and system for identifying diagnostic and therapeutic options for medical conditions using electronic health records
WO2018094125A1 (en) * 2016-11-17 2018-05-24 Laboratory Corporation Of America Holdings Methods and systems for measuring plasma renin activity
CN106770824A (zh) * 2016-12-21 2017-05-31 河南出入境检验检疫局检验检疫技术中心 利用高分辨质谱仪检测血浆中痕量醛固酮的方法
JP7067758B2 (ja) * 2017-06-30 2022-05-16 国立大学法人 新潟大学 試料中のアンジオテンシンペプチドの量を測定するための方法及びアンジオテンシンペプチドの定量キット
CN112037931B (zh) * 2020-07-15 2023-10-20 新疆维吾尔自治区人民医院 在疑似原发性醛固酮增多症中应用的醛固酮增多预测体系
CN112014509A (zh) * 2020-09-03 2020-12-01 复旦大学附属中山医院 同步测定样品中血管紧张素i和醛固酮的方法
CN113533552B (zh) * 2021-06-02 2023-08-29 杭州凯莱谱精准医疗检测技术有限公司 液相色谱串联质谱检测肾素活性过程中对影响arr药物同步检测的方法
CN117554603B (zh) * 2023-11-28 2024-05-10 中国医学科学院阜外医院 一种用于原发性醛固酮增多症初筛的标志物组合及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3919407A (en) * 1973-11-28 1975-11-11 De Castro Aurora L Fernandez Method for quantitative determination of renin activity in blood
JPH022935A (ja) * 1988-06-20 1990-01-08 Tosoh Corp アンジオテンシンの測定法
US5314804A (en) * 1992-03-24 1994-05-24 Serim Research Corporation Test for Helicobacter pylori
AU2002304965A1 (en) * 2002-05-24 2003-12-12 Zensun (Shanghai) Sci-Tech.Ltd Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy
WO2007109733A2 (en) * 2006-03-21 2007-09-27 The Johns Hopkins University Diagnostic and prognostic markers and treatment strategies for multiple sclerosis
NZ571820A (en) * 2006-05-29 2010-09-30 Nicox Sa Nitrated heterocyclic compounds as endothelin receptor antagonist
WO2008103420A1 (en) * 2007-02-21 2008-08-28 The Regents Of The University Of Michigan Compositions and methods for tranquilizing heart muscle
EP2225559B8 (en) * 2007-12-28 2016-12-21 F. Hoffmann-La Roche AG Assessment of physiological conditions
AU2013230886B2 (en) * 2012-03-08 2015-10-01 Medtronic Af Luxembourg S.A.R.L. Renal neuromodulation methods and systems for treatment of hyperaldosteronism
CN102586223A (zh) * 2012-03-08 2012-07-18 南京大学 一种基于mypt1基因敲除建立新型高血压小鼠模型的方法及其用途
US9829496B2 (en) * 2013-10-18 2017-11-28 Attoquant Diagnostics Gmbh Method for diagnosis of primary hyperaldosteronism

Also Published As

Publication number Publication date
PL3058374T3 (pl) 2020-02-28
US9829496B2 (en) 2017-11-28
EP3058374A1 (en) 2016-08-24
BR112016007960B8 (pt) 2023-11-14
JP6397907B2 (ja) 2018-09-26
US10295552B2 (en) 2019-05-21
EA201690796A1 (ru) 2016-08-31
US20160266151A1 (en) 2016-09-15
AU2014336122B2 (en) 2020-06-25
US20180164330A1 (en) 2018-06-14
WO2015055825A1 (en) 2015-04-23
AU2014336122A1 (en) 2016-04-07
NZ717888A (en) 2022-03-25
EA035289B1 (ru) 2020-05-25
BR112016007960A8 (pt) 2020-03-17
BR112016007960B1 (pt) 2023-03-07
ES2745099T3 (es) 2020-02-27
CN105683760A (zh) 2016-06-15
JP2017500538A (ja) 2017-01-05
CA2926382C (en) 2020-06-02
CA2926382A1 (en) 2015-04-23
HUE045337T2 (hu) 2019-12-30
EP3058374B1 (en) 2019-06-26

Similar Documents

Publication Publication Date Title
DK3058374T3 (da) Fremgangsmåde til diagnose af primær hyperaldosteronisme
DK3076967T3 (da) Fremgangsmåder til behandling af residuelle symptomer på skizofreni
DK3227804T3 (da) Forhåndsdiagnose af funktionsevne for infusionsanordnings driftsmodus
DK3611262T3 (da) Fremgangsmåder til sekvensering af immunrepertoire
DK3006568T3 (da) Fremgangsmåde til fremstilling af tagatose
DK3083540T3 (da) Fremgangsmåde til fremstilling af substituerede phenoxyphenylketoner
DK3117030T3 (da) Diagnosticering af sepsis
DK3020727T4 (da) Mutant calreticulin til diagnose af myeloide maligniteter
DK2972353T3 (da) Forbedrede fremgangsmåder til udførelse af multipleksanalyser
DK2970951T3 (da) Fremgangsmåder til nukleinsyresekventering
DK3940352T3 (da) Fremgangsmåde til diagnosticering af vægte
DK3010895T3 (da) Fremgangsmåde til fremstilling af 4-propargyleret aminobenzoxazinoner
DK3007726T3 (da) Fremgangsmåder til behandling af en tauopati
DK3041349T3 (da) Anordning til angrebsdiagnose
DK3005298T3 (da) Fremgangsmåde til rekonstruktion af et objekt fra projektionsafbildninger
DK3068359T3 (da) Indikator for hældningen af sengen
DK2969098T3 (da) Fremgangsmåder til oprensning af antistoffer
DK3071670T3 (da) Integreret fremgangsmåde til fremstilling af carbonhydrider
DK3233813T3 (da) Fremgangsmåder til fremstilling af oxathiazin-lignende forbindelser
DK2836460T3 (da) Fremgangsmåde til fremstilling af graphen
DK2988659T3 (da) Forbedrede fremgangsmåder til vævskarakterisering
DK2991543T3 (da) System til visualisering af kropsområder
DK2908724T3 (da) Fremgangsmåde til at følge udviklingen af en hjernelæsion
DK2985275T3 (da) Fremgangsmåde til oprensning af beta-hydroxy-beta-methylsmørsyre
FI20135397A (fi) Testausadapteri